NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Turkish Version of the Neurogenic Bladder Symptom Score Short Form

CompletedN/A

Sponsor: Gaziantep Islam Science and Technology University

Conditions: Neurogenic Bladder Disorder, Spinal Cord Injury, Multiple Sclerosis, Lower Urinary Track Symptoms

Countries: Turkey (Türkiye)

This observational study aims to evaluate the cross-cultural adaptation and psychometric properties of the Turkish version of the Neurogenic Bladder Symptom Score Short Form (NBSS-SF) in adults with spinal cord injury or multiple sclerosis who have neurogenic lower urinary tract dysfunction. Neurogenic bladder symptoms, such as urinary incontinence, urgency, and difficulties with urine storage or emptying, may negatively affect daily functioning and quality of life. In this study, the validity and reliability of the Turkish NBSS-SF will be examined, and convergent validity will be assessed through its relationship with the King's Health Questionnaire (KHQ) and the Short Form-12 (SF-12). In eligible participants, the scale will be administered again after 7 to 14 days. The aim of the study is to provide a valid and reliable Turkish patient-reported outcome measure for use in clinical practice and research.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Being ≥18 years old

  * Having a diagnosis of Spinal Cord Injury (SCI) or Multiple Sclerosis (MS) and neurogenic lower urinary tract dysfunction
  * Being able to read and understand Turkish and have the cognitive ability to independently complete questionnaires
  * Can be included with any bladder management method (spontaneous voiding, CIC, permanent catheter, condom catheter, reconstruction/diversion etc.)
  * Volunteering and signing informed consent

Exclusion Criteria:

* Having an active urinary tract infection (UTI)
* Having undergone urological surgery in the last month
* Reporting changes in bladder/urinary function between the first and second applications (surgery, UTI, change in bladder medication)
* Having a significant recent change in general health status
* Having a spinal cord injury (SCI) in the spinal shock phase
* Having experienced a relapse of Multiple Sclerosis (MS) within the last 3 months.

Locations (1)

Ankara, Çankaya, Turkey (Türkiye)